Clinical Trial Update: Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assesses the safety and preliminary efficacy of AAV-DC-CTL therapy in patients with stage IV gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• AAV-DC-CTL

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Stage IV Gastric Cancer | Phase 1 | Status: UNKNOWN